The anti-diabetic drug metformin rescues aberrant mitochondrial activity and restrains oxidative stress in a female mouse model of Rett syndrome
10.3390/jcm9061669 · doi-reference
GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease
10.1016/j.molmet.2021.101180 · doi-reference
Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation
10.7554/elife.13374 · doi-reference
Metabolic reprogramming in astrocytes results in neuronal dysfunction in intellectual disability
10.1038/s41380-022-01521-x · doi-reference
Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer’s disease
10.1016/j.ebiom.2015.03.009 · doi-reference
Pyruvate kinase deficiency: the genotype-phenotype association
10.1016/j.blre.2007.01.001 · doi-reference
Hemolytic anemia and severe rhabdomyolysis caused by compound heterozygous mutations of the gene for erythrocyte/muscle isozyme of aldolase, ALDOA(Arg303X/Cys338Tyr)
10.1182/blood-2003-09-3160 · doi-reference
Astrocyte-derived lactate aggravates brain injury of ischemic stroke in mice by promoting the formation of protein lactylation
10.7150/thno.96375 · doi-reference
Infantile form of muscle phosphofructokinase deficiency in a premature neonate
10.1111/ped.12616 · doi-reference
Clinical, neuroimaging, and metabolic footprint of the neurodevelopmental disorder caused by monoallelic HK1 variants
10.1212/nxg.0000000000200146 · doi-reference
The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis
10.1016/j.cell.2025.05.029 · doi-reference
Mesenchymal stem cells and purinergic Signaling in autism Spectrum disorder: bridging the gap between cell-based strategies and neuro-immune modulation
10.3390/biomedicines12061310 · doi-reference
Aerobic glycolysis is the predominant means of glucose metabolism in neuronal somata, which protects against oxidative damage
10.1038/s41593-023-01476-4 · doi-reference
BACH1 changes microglial metabolism and affects astrogenesis during mouse brain development
10.1016/j.devcel.2023.11.018 · doi-reference
Axin2 coupled excessive Wnt-glycolysis signaling mediates social defect in autism spectrum disorders
10.15252/emmm.202217101 · doi-reference
Glucose transporter 1 critically controls microglial activation through facilitating glycolysis
10.1186/s13024-019-0305-9 · doi-reference
Unusual presentation of phosphoglycerate mutase deficiency due to two different mutations in PGAM-M gene
10.1016/j.nmd.2009.08.007 · doi-reference
Adenosine signalling to astrocytes coordinates brain metabolism and function
10.1038/s41586-024-07611-w · doi-reference
Brain fuel utilization in the developing brain
10.1159/000508054 · doi-reference
Mitochondrial bioenergetic is impaired in monocarboxylate transporter 1 deficiency: a new clinical case and review of the literature
10.1186/s13023-022-02389-4 · doi-reference
Triosephosphate isomerase deficiency: E105D mutation in unrelated patients and review of the literature
10.1159/000528192 · doi-reference
GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier
10.1038/ng0298-188 · doi-reference
LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson’s disease patients: reversal by gene correction
10.1016/j.nbd.2013.10.013 · doi-reference
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor
10.1038/nm.4106 · doi-reference
Missense variant in TPI1 (Arg189Gln) causes neurologic deficits through structural changes in the triosephosphate isomerase catalytic site and reduced enzyme levels in vivo
10.1016/j.bbadis.2019.05.002 · doi-reference
Neuronal immunoproteasome and PFKFB3-forced glycolysis: key players in multiple sclerosis
10.1038/s41392-025-02372-y · doi-reference
Mesenchymal stem cell-derived extracellular vesicles alleviate autism by regulating microglial glucose metabolism reprogramming and neuroinflammation through PD-1/PD-L1 interaction
10.1186/s12951-025-03250-z · doi-reference
Expanding the neurodevelopmental phenotype associated with HK1 de novo heterozygous missense variants
10.1016/j.ejmg.2023.104696 · doi-reference
10.1016/j.cell.2023.11.011
10.1016/j.cell.2023.11.011 · doi-reference
Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization
10.1073/pnas.91.22.10625 · doi-reference
The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients
10.1016/j.ymgme.2012.03.017 · doi-reference
De novo variants in HK1 associated with neurodevelopmental abnormalities and visual impairment
10.1038/s41431-019-0366-9 · doi-reference
Human pluripotent stem cell (hPSC)-derived models for autism spectrum disorder drug discovery
10.1080/17460441.2024.2416484 · doi-reference
The neuroimaging findings of monocarboxylate transporter 1 deficiency
10.1007/s00234-020-02435-7 · doi-reference
Case report: A novel hemizygous missense PDHA1 variant in a Vietnamese boy with pyruvate dehydrogenase E1-alpha deficiency
10.3389/fped.2024.1494604 · doi-reference
Phosphofructokinase deficiency; past, present and future
10.2174/1566524024605734 · doi-reference
Oligodendroglia: metabolic supporters of axons
10.1016/j.tcb.2013.07.007 · doi-reference
Loss of microglial MCT4 leads to defective synaptic pruning and anxiety-like behavior in mice
10.1038/s41467-023-41502-4 · doi-reference
Identification of human D lactate dehydrogenase deficiency
10.1038/s41467-019-09458-6 · doi-reference
Restoring hippocampal glucose metabolism rescues cognition across Alzheimer's disease pathologies
10.1126/science.abm6131 · doi-reference
